Kaye Capital Management Amgen Inc Transaction History
Kaye Capital Management
- $213 Million
- Q1 2025
A detailed history of Kaye Capital Management transactions in Amgen Inc stock. As of the latest transaction made, Kaye Capital Management holds 1,013 shares of AMGN stock, worth $283,700. This represents 0.15% of its overall portfolio holdings.
Number of Shares
1,013
Previous 1,012
0.1%
Holding current value
$283,700
Previous $263,000
19.77%
% of portfolio
0.15%
Previous 0.13%
Shares
9 transactions
Others Institutions Holding AMGN
# of Institutions
3,267Shares Held
422MCall Options Held
6.98MPut Options Held
6.33M-
Vanguard Group Inc Valley Forge, PA52.9MShares$14.8 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.9 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$8.24 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.08 Billion0.27% of portfolio
-
Geode Capital Management, LLC Boston, MA12.5MShares$3.49 Billion0.26% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $150B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...